Explore the debate over regulatory data protection in India, its impact on pharmaceutical research, and how it balances intellectual property rights with access to medicines. Learn about India’s approach and its implications for the generic industry. Continue Reading Pharmaceutical Regulatory Data Protection in India
In the case of PPL versus LOOKPART EXHIBITIONS (CS (COMM) 188/2022 & I.A 4772/2022), The Delhi High Court asked Professor Arul George Scaria to provide an expert opinion on Section 52(1)(za). The Court asked Professor Arul to particularly provide an opinion on the scope and extent of the Copyright Exception with respect to the use of Sound Recordings in marriage ceremonies and related festivities. In furtherance, Professor Arul gave his opinion to the Court, which was mentioned in the Court’s…
Date of First Publication: 4th January 2010
Dr. Kalyan needs to be thanked for the timely post (dated 3rd January) on the current controversy over the credits for the movie "3 Idiots". Let me take this opportunity to air a couple of observations/questions on related issues:
1. Can the author, in this instance a fairly well known and popular author Mr. Chetan Bhagat, contract away his "moral rights" specifically, and not through the mode of assignment of copyrights of the work? Nothing…
First Publication Date: 7th January 2008
Monopoly and related rights have always been frowned upon by the law. The Statute of Monopolies, enacted in England in the year 1623, established that monopolies are not acceptable in law, but made a glorious exception in favour of patentable inventions. Therefore, although the statute prohibited monopolies, it specifically preserved the right of the royalty to grant patents for inventions by manufacturers.
In pursuance of this individual government backed incentive mechanisms that prevailed in different parts…
The recent amendment to the Agreement on Trade Related Aspects of Intellectual Property Rights (TRIPS) is the first ever amendment to WTO accords after its founding in 1995. The amendment to the TRIPs agreement came into force on 23rd January, 2017, after 2/3rd members of WTO accepted it. The amendment facilitates supply of drugs to developing/least developed countries lacking pharmaceutical production capacity under a compulsory license. The amendment was made to address public health needs of people in poor countries…
India approved its first ever Intellectual Property Rights (IPR) policy with a vision to stimulate creativity and innovation and to promote advancement in science and technology, arts and culture, traditional knowledge and biodiversity resources.
The policy lays out seven broad objectives and they are as follows:
Awareness: outreach and promotion;
Generation of IPRs;
Legal and legislative framework;
Administration and management;
Commercialization of IPR;
Enforcement and adjudication; and
Human capital development.
This article considers various…